Clene Inc. cotiza a 3.39 USD y tiene una capitalización bursátil de $48M. En los últimos 12 meses ha facturado $197000 con un margen de flujo de caja libre del -9292.5%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Consumo defensivo
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to ev…
| Periodo | 2026-05 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-0.24 | $-0.78 | $-0.61 | $-0.88 |
| Estimado | $-0.70 | $-0.42 | $-0.56 | $-0.46 |
| Sorpresa | +65.7% | -85.7% | -8.9% | -91.3% |
| Métrica | CLNN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 78.5% | 30.7% | +47.8% |
| Operating Margin | -11541.5% | 1.0% | -11542.5% |
| Net Margin | -13086.5% | 0.8% | -13087.3% |
| FCF Margin | -9292.5% | 2.4% | -9294.9% |
| ROE | — | 5.2% | — |
| ROA | -144.4% | 0.6% | -145.0% |
| Current Ratio | 0.83 | 1.35 | -0.52 |
| Debt / Equity | -1.01 | 0.37 | -1.38 |